🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Vascular Changes Associated With Endophthalmitis.

Recruitingn/aAges 18 Years - anyAllAsociación para Evitar la Ceguera en México
NCT07175311 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

This study aims to describe and investigate vascular changes associated with exogenous endophthalmitis, as well as to create a photo library where they are evidenced

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Patients with a history of endophthalmitis Diagnosis of Endophthalmitis * Clinical symptoms: Pain, decrease in visual acuity, anterior chamber cells and/or vitreous turbidity, corneal edema, conjunctival hyperemia * Laboratory studies: B-mode USG and or positive culture * Patients who meet the endophthalmitis resolution criteria of the Mexican Endophthalmitis Study Group * Patients with previously signed informed consent Exclusion Criteria: * Patients who have not signed the informed consent * Patients under 18 years. * Patients with endophthalmitis who do not meet the resolution criteria of the Mexican Endophthalmitis Study Group
💊

What it tests

  • Multimodal imaging findings
📍

Where

1 site
Hospital Asociación Para Evitar la Ceguera en México I.A.P.
Mexico City, Mexico
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy